BERKELEY, Calif.--(BUSINESS WIRE)--Nanotein Technologies, Inc. (“Nanotein”), a technology development company with next-generation immune cell activation reagents leveraging its proprietary NanoSpark® ...
Xcellara™ Stem Cell Activator has been scientifically shown to significantly increase circulating stem cells in humans, dogs, horses, and other mammals. Stem cells foster cellular regeneration and ...
Prognosis is extremely poor for patients with head and neck squamous cell carcinoma (HNSCC), which accounts for around 90% of all head and neck cancer. Especially in the more aggressive subtype of ...